3-Bromo-5,7-dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine

Catalog No. :
ACKKXV480
CAS No. :
1033444-08-4
Molecular Formula :
C6H3BrCl2N4
Molecular Weight :
281.93

IUPAC Name:3-bromo-5,7-dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine

3-Bromo-5,7-dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$566.00Login to see priceInquiryInquiry
100mg97%$732.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5,7-dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine
IUPAC Name3-bromo-5,7-dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine
MDL No.MFCD29058840
Molecular FormulaC6H3BrCl2N4
Molecular Weight281.93
SMILESCN1N=C(Br)C2=NC(Cl)=NC(Cl)=C21
InChI KeySAPXRFLCBKPBFP-UHFFFAOYSA-N
Synonym3-bromo-5,7-dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine;1H-Pyrazolo[4,3-d]pyrimidine, 3-bromo-5,7-dichloro-1-methyl-
CAS No.1033444-08-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKKXV480 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZQRB853 route compound structure diagram
    ACZQRB8531934543-12-0 In Stock
  4. Then
  5. ACKKXV480 route product structure diagram
    ACKKXV4801033444-08-4
Inquiry

2. ACKKXV480 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACZQRB853 route compound structure diagram
    ACZQRB8531934543-12-0 In Stock
  4. Then
  5. ACKKXV480 route product structure diagram
    ACKKXV4801033444-08-4
Inquiry

Comments (0)